Related Experiment Video
Updated: Jun 1, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Role of cardiovascular risk factors (CRF) in the patients with mild cognitive impairment (MCI)
E Ettorre1, E Cerra, B Marigliano
1Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences Sapienza University of Rome, Umberto I, Policlinico di Roma. Viale del Policlinico 155, I-00161 Roma, Italy.
Insights
Controlling cardiovascular risk factors (CRF) significantly impacts cognitive decline in mild cognitive impairment (MCI). Patients with MCI and CRF progress to Alzheimer
Area of Science:
- Neurology
- Geriatrics
- Public Health
Background:
- Limited therapeutic options exist for Alzheimer's disease (AD).
- Evidence suggests controlling vascular risk factors may modify AD progression.
- Cardiovascular risk factors (CRF) are increasingly recognized as potential contributors to cognitive decline.
Purpose of the Study:
- To investigate the role of CRF in patients with mild cognitive impairment (MCI).
- To evaluate the influence of CRF on cognitive and behavioral features in MCI.
- To assess the impact of CRF on the progression from MCI to dementia.
Main Methods:
- Study included 50 patients diagnosed with MCI using Petersen's criteria.
- Patients were assessed for the presence of cardiovascular risk factors (CRF).
- Cognitive status, behavioral features, and progression to dementia were monitored over time.
Main Results:
- 60% of MCI patients with CRF progressed to dementia, versus 32% without CRF.
- MCI patients with CRF exhibited worse cognitive performance.
- MCI patients with CRF also showed increased behavioral disorders, depression, and functional disability.
Conclusions:
- Cardiovascular risk factors play a key role in the cognitive decline of MCI patients.
- MCI patients with CRF have a higher conversion rate to AD.
- Early management of CRF may be crucial for mitigating cognitive decline in MCI.
Abstract:
Few therapeutic options are available nowadays to improve the prognosis of patients with Alzheimer's disease (AD). There are rather several evidences in literature that controlling vascular risk factors may be an effective intervention for modifying the course of this disease. The aim of our study was to investigate the role of CRF in 50 patients with MCI according to Petersens's criteria, and to evaluate their influence on cognitive and behavioral features of the disease and on the development of dementia. Statistical analysis of the data showed that the 60% of the patients with MCI and CRF developed dementia, while 40% maintained the same cognitive conditions at the end of the study. Only 32% of the subjects without cardiovascular comorbidities developed dementia. The results of the study suggest that CRF play a key role in cognitive decline of patients with MCI. Patients with MCI and CRF showed not only worse cognitive performances, but also behavioral disorders, depression and functional disability. Patients with CRF had higher conversion rate to AD than the other group, with a mean disease-free period 3 months shorter than the control group.
More Related Videos
Related Concept Videos
Dementia l: Introduction
Imaging Studies for Cardiovascular System IV: CMRI
Alzheimer Disease l: Introduction
Atherosclerosis III: Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction

